Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jκ

Journal of General Virology

Volumn 79, Issue 2, 1998, Pages 363-370

  Bourillot, Pierre Yves ^a   Waltzer, Lucas ^a   Sergeant, Alain ^a   Manet, Evelyne ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA BINDING PROTEIN; EPSTEIN BARR VIRUS ANTIGEN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE REPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4; MAMMALIA;

EID: 0031964949     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-2-363     Document Type: Article

References (44)

1. Abbot, S. D., Rowe, M., Cadwallader, K., Ricksten, A., Gordon, J., Wang, F., Rymo, L. & Rickinson, A.B. (1990). Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. Journal of Virology 64, 2126-2134.
2. Allday, M. J. & Farrell, P. J. (1994). Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells. Journal of Virology 68, 3491-3498.
3. Bain, M., Watson, R. J., Farrell, P. J. & Allday, M. J. (1996). Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. Journal of Virology 70, 2481-2489.
4. Calender, A., Billaud, M., Aubry, J.-P., Banchereau, J., Vuillaume, M. & Lenoir, G. M. (1987). Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proceedings of the National Academy of Sciences, USA 84, 8060-8064.
5. Cohen, J. F., Wang, F., Mannick, J. & Kieff, E. (1989). Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proceedings of the National Academy of Sciences, USA 86, 9558-9562.
6. Cordier, M., Calender, A., Billaud, M., Zimber, U., Rousselet, G., Pavlish, O., Banchereau, J., Tursz, T., Bornkamm, G. & Lenoir, G. M. (1990). Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. Journal of Virology 64, 1002-1013.
7. Dou, S., Zeng, X., Cortes, P., Erdjument-Bromage, H., Temps, P., Honjo, T. & Vales, L. D. (1994). The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Molecular and Cellular Biology 14, 3310-3319.
8. Fahraeus, R., Jansson, A., Ricksten, A., Sjöblom, A. & Rymo, L. (1990). Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proceedings of the National Academy of Sciences, USA 87, 7390-7394.
9. Grossman, S. R., Johannsen, E., Tong, X., Yalamanchili, R. & Kieff, E. (1994). The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the Jκ recombination signal binding protein. Proceedings of the National Academy of Sciences, USA 91, 7568-7572.
10. Hammerschmidt, W. & Sugden, B. (1989). Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393-397.
11. Hammerschmidt, W. B., Sugden, B. & Baichwal, V. (1989). The transforming domain alone of latent membrane protein of Epstein-Barr virus is toxic when expressed at high levels. Journal of Virology 63, 2469-2475.
12. Henkel, T., Ling, P. D., Hayward, L. S. D. & Peterson, M. G. (1994). Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jκ. Science 265, 92-95.
13. Hsieh, J. J.-D. & Hayward, S. D. (1995). Masking of the CBF1/RBPJκ transcriptional repression domain by Epstein-Barr virus EBNA2. Science 238, 560-563.
14. Kallin, B., Dillner, J., Ernberg, I., Ehlin-Henriksson, B., Rosen, A., Henle, W. & Klein, G. (1986). Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proceedings of the National Academy of Sciences, USA 83, 1499-1503.
15. Kaye, K. M., Izumi, K. M. & Kieff, E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B lymphocytes growth transformation. Proceedings of the National Academy of Sciences, USA 68, 9150-9154.
16. Kempkes, B., Spitkovsky, D., Jansen-Dürr, P., Ellwart, J. W., Kremmer, E., Delecluse, H.-J., Rottenberger, C., Bornkamm, G. W. & Hammerschmidt, W. (1995). B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO Journal 14, 88-96.
17. Kieff, E. D. (1996). Epstein-Barr virus. In Fields Virology, 3rd edn, pp. 2343-2396. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
18. Kienzle, N., Young, D., Silins, S. & Sculley, T. B. (1996). Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family. Virology 224, 167-174.
19. Knuston, J. C. (1990). The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for cell immortalization. Journal of Virology 64, 2530-2536.
20. Krauer, K. G., Kienzle, N., Young, D. B. & Sculley, T. B. (1996). Epstein-Barr nuclear antigen-3 and-4 interact with RBP2N a major isoform of RBP-Jκ in B lymphocytes. Virology 226, 346-353.
21. Le Roux, A., Kerdiles, B., Walls, D., Dedieu, J. F. & Perricaudet, M. (1994). The Epstein-Barr virus determined nuclear antigens EBNA-3A, 3B, 3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205, 596-602.
22. Ling, P. D., Rawlins, D. R. & Hayward, S. D. (1993). The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proceedings of the National Academy of Sciences, USA 90, 9237-9241.
23. Mannick, J. B., Cohen, J. L., Birkenbach, M., Marchini, A. & Kieff, E. (1991). The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs (EBNA-LP) is important in B-lymphocyte transformation. Journal of Virology 65, 6826-6837.
24. Marshall, D. & Sample, C. (1995). Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. Journal of Virology 69, 3624-3630.
25. Martin, J. M., Veis, D., Korsmeyer, S. J. & Sugden, B. (1993). Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. Journal of Virology 67, 5269-5278.
26. Parker, G. A., Crook, T., Bain, M., Sara, E. A., Farrell, P. J. & Allday, M. J. (1996). Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13, 2541-2549.
27. Robertson, E. S., Grossman, S., Johannsen, E., Miller, C., Lin, J., Tomkinson, B. & Kieff, E. (1995). Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein Jκ. Journal of Virology 69, 3108-3116.
28. Robertson, E. S., Lin, J. & Kieff, E. (1996). The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B and 3C interact with RBPJκ. Journal of Virology 70, 3068-3074.
29. Rooney, C. M., Brimmell, M., Buschle, M., Allan, G., Farrell, P. J. & Kolman, J. L. (1992). Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. Journal of Virology 66, 496-504.
30. Silins, S. L. & Sculley, T. B. (1994). Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4. Virology 202, 16-24.
31. Sinclair, A. J., Palmero, I., Peters, G. & Farrell, P. J. (1994). EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO Journal 13, 3321-3328.
32. Sung, N. S., Kenney, S., Gutsch, D. & Pagano, J. S. (1991). EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. Journal of Virology 65, 2164-2169.
33. Tomkinson, B., Robertson, E. & Kieff, E. (1993). Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. Journal of Virology 67, 2014-2025.
34. Waltzer, L., Bourillot, P. Y., Sergeant, A. & Manet, E. (1995). RBP-Jκ repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2. Nucleic Acids Research 23, 4939-4945.
35. Waltzer, L., Logeat, F., Brou, C., Israel, A., Sergeant, A. & Manet, E. (1994). The human Jκ recombination signal sequence binding protein (RBP-Jκ) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO Journal 13, 5633-5638.
36. Waltzer, L., Perricaudet, M., Sergeant, A. & Manet, E. (1996). Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-Jκ-EBNA2-activated transcription by inhibiting the binding of RBP-Jκ to DNA. Journal of Virology 70, 5909-5915.
37. Wang, F., Gregory, C., Sample, C., Rowe, M., Liebowitz, D., Murray, R., Rickinson, A. & Kieff, E. (1990a). Epstein-Barr virus latent membrane protein (LMP1) and nuclear antigen 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. Journal of Virology 64, 2309-2318.
38. Wang, F., Tsang, S.-F., Kurilla, M. G., Cohen, J. I. & Kieff, E. (1990b). Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. Journal of Virology 64, 3407-3416.
39. Webster, N., Green, S., Tasset, D., Ponglikitmongkol, M. & Chambon, P. (1989). The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon. EMBO Journal 8, 1441-1446.
40. Woisetchlaeger, M., Yandava, C. N., Furmanski, L. A., Strominger, J. L. & Speck, S. (1990). Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. 87, 1725-1729.
41. Yalamanchili, R., Tong, X., Grossman, S., Johannsen, E., Mosialos, G. & Kieff, E. (1994). Genetic and biochemical evidence that EBNA2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Virology 204, 634-641.
42. Zhao, B., Marshall, D. R. & Sample, C. E. (1996). A conserved domain of the Epstein-Barr virus nuclear antigen 3A and 3C binds to a discrete domain of Jκ. Journal of Virology 70, 4228-4236.
43. Zimber-Strobl, U., Suentzenich, K.-O., Laux, G., Eick, D., Cordier, M., Calender, A., Billaud, M., Lenoir, G. M. & Bornkamm, G. W. (1991). Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. Journal of Virology 65, 415-423.
44. Zimber-Strobl, U., Strobl, L. J., Meitinger, C., Hinrichs, R., Sakai, T., Furukawa, T., Honjo, T. & Bornkamm, G. (1994). Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-Jκ, the homologue of Drosophila Suppressor of Hairless. EMBO Journal 13, 4973-4982.